...to address use-related errors. In fact, the head of the FDA’s advisory committee on painkillers argued the drug would likely worsen the opioid crisis. According to the FDA-approved label, Dsuvia...
...to address use-related errors. In fact, the head of the FDA’s advisory committee on painkillers argued the drug would likely worsen the opioid crisis. According to the FDA-approved label, Dsuvia...
...bill now sits with the Labor and Workforce Development Committee, Meanwhile, the Pennsylvania Commonwealth Court recently overturned two previous decisions made by the Pennsylvania Workers’ Compensation Appel Board which denied...
...level of small molecule generic introductions over the past five years, indicating that more biosimilars may soon be coming down the drug development pipeline. And on the subject of drug...
...challenges, there is one asset that can perhaps be leveraged more optimally as a mitigator of claim complexity – the injured worker patient. Even as workers’ compensation programs have been...
...lead to low levels of amniotic fluid surrounding the baby and possible complications. NSAIDs are commonly used to relieve pain, and they are regularly used in workers’ comp. Common NSAIDs...
...duplicate bills that come through on 150 claims. That is time which can now be applied to meaningful work. Couple this with clinical logic that helps detect complexity that may...
...sweating mechanism fails. In workers’ compensation, heat-related illnesses are prevalent. A study by the UCLA Luskin School of Public Affairs compared records from more than 11 million California workers’ comp...
...following federal workers’ comp programs: The Division of Federal Employees Compensation (DFEC) The Division of Coal Mine Workers’ Compensation (DCMWC) The Division of Energy Employees Occupational Illness Compensation (DEEOIC) The...
...in workers’ comp present concerns for both their therapeutic appropriateness and cost. Let’s look at the different types of topical medications and their cost and efficacy considerations in workers’ comp....
The FDA issued an alert to providers, compounders, and patients of dosing errors associated with compounded injectable semaglutide products, due to reports of adverse events, some requiring hospitalization, that may...
